We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website.

DeHCA Biomarker

DeHCA is a newly identified biomarker that represents the variation of concentration of deoxyhemoglobin within the breast tissues and its abnormal values can be associated to the neoangiogenesis at the root of the formation of new tumours.

The measurement of the DeHCA biomarker is independent from breast density, therefore suitable to detect cancer in dense breasts, providing image of the tumour feeding vessels, before the tumour is visible by a morphological examination. This results in less invasive interventions, possibility to treat the tumour before it spreads to nearby parts of the body, tuning therapies, saving lives.